Protagenic Therapeutics (PTIX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.41
• Market Cap: $786,580
• EPS: $-13.13
• 52-Week High: $14.28
• 52-Week Low: $0.25

About Protagenic Therapeutics

Protagenic Therapeutics, Inc. (PTIX) is a preclinical biopharmaceutical firm headquartered in New York, specializing in the development of innovative therapies aimed at treating stress-related mood and neuropsychiatric disorders. The company utilizes advanced research methodologies and cutting-edge technologies to identify and address significant unmet medical needs within this vital sector. With a strong commitment to enhancing patient mental health outcomes, Protagenic Therapeutics is posit...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Protagenic Therapeutics and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PTIX pay dividends?

Protagenic Therapeutics (PTIX) does not currently pay a regular dividend.

What is PTIX's market cap?

Protagenic Therapeutics (PTIX) has a market capitalization of $786,580 with a current stock price of $0.41.